CytoMed Therapeutics Limited Income Tax Expense Continuing Operations
CytoMed Therapeutics Limited (GDTC) reported Income Tax Expense Continuing Operations of SGD 653 for the 12-month period ending 2023-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2026-03-31
SGD
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2023-12-31 | 653.00 SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 1.64K SGD 20-F · filed 2025-04-28 |
USD
| Period end | Income Tax Expense Continuing Operations 12 month |
|---|---|
| 2023-12-31 | $495.00 20-F · filed 2024-04-22 |
| 2022-12-31 | $1.22K 20-F · filed 2023-05-01 |